Neurofibromatosis type 1 with bladder involvement
- PMID: 23984171
- PMCID: PMC3745892
- DOI: 10.1155/2013/145076
Neurofibromatosis type 1 with bladder involvement
Abstract
Neurofibromatosis type 1 is an autosomal dominant transmitted disease with various clinical manifestations. The bladder is the most commonly affected organ in the genitourinary system. The malignant transformation of the disease is rare, and unlike malign tumors, the treatment option for benign disease is usually conservative. The size and localization of the mass determine the symptoms, most of which are usually not specific. In this paper, we aim to present a 15-year-old patient with neurofibromatosis type 1 with bladder involvement. The clinical presentation and treatment options of this disease are discussed in the light of the literature.
Figures


References
-
- Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genetics in Medicine. 2010;12(1):1–11. - PubMed
-
- Scheithauer BW, Santi M, Richter ER, Belman B, Rushing EJ. Diffuse ganglioneuromatosis and plexiform neurofibroma of the urinary bladder: report of a pediatric example and literature review. Human Pathology. 2008;39(11):1708–1712. - PubMed
-
- Chakravarti A, Jones MA, Simon J. Neurofibromatosis involving the urinary bladder. International Journal of Urology. 2001;8(11):645–647. - PubMed
-
- Karatzoglou P, Karagiannidis A, Kountouras J, et al. Von Recklinghausen’s disease associated with malignant peripheral nerve sheath tumor presenting with constipation and urinary retention: a case report and review of the literature. Anticancer Research. 2008;28(5 B):3107–3113. - PubMed
-
- Hintsa A, Lindell O, Heikkilä P. Neurofibromatosis of the bladder. Scandinavian Journal of Urology and Nephrology. 1996;30(6):497–499. - PubMed
LinkOut - more resources
Full Text Sources